In our own study, 18 of the 20 patients with SMAD4 positivity died within 6 months of diagnosis and 2 (low positivity SMAD4 expression) of the 20 patients were still alive 7 and 9 months after diagnosis of pancreatic adenocarcinoma. This evidence concerns the gene SMAD4 and pancreatic adenocarcinoma.